[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hospitalism\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hospitalism":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,41],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100560494","immersive-sensory-projections-for-hospitalized-patients-100560494",false,"NCT06577870","Immersive Sensory Projections for Hospitalized Patients","Immersive Sensory Projections: Evaluating the Impact of an Immersive Sensory Environment (Visual, Auditory and Olfactory) on Reducing the Overall Discomfort of Patients Hospitalized in the Resuscitation and Continuing Care Units","IHP","Inclusion Criteria:\n\n* Age ≥ 18 years ;\n* Patient hospitalized in intensive care or continuing care unit for an estimated minimum of 48 hours;\n* Patient hospitalized for a medical indication (including in the pre-surgical phase) or in the post-surgical phase;\n* Patient or support person who speaks and understands French, has understood the research procedures and is able to complete the questionnaires;\n* For women of childbearing age (non-menopausal), even for those on contraception: negative pregnancy test (urinary); If positive: completed by a biological test;\n* Patient or trusted support person having been informed and having signed an informed consent form to participate in the study.\n\nExclusion Criteria:\n\n* Deaf or blind patient;\n* Asthmatic patient with background treatment;\n* Epileptic patient or known history of convulsion;\n* Known allergy or intolerance to essential oils or to a component of essential oils;\n* Patient transferred from another intensive care unit;\n* Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision);\n* Breast-feeding or pregnant women;\n* Patient or support person unable to understand information relating to the study (linguistic, psychological, cognitive, etc.);\n* Unconscious patient with no relative or support person present;\n* Homeless patient;\n* Patient with known severe psychiatric illness such as chronic hallucinatory psychosis or paranoid syndrome;\n* Patient participating in or being excluded from another clinical trial;\n* Patient not covered by a social security scheme.","ALL","18 Years",{"count":20,"type":21},208,"ESTIMATED","INTERVENTIONAL",[24],"NA","The purpose of this study is to assess the impact of adding three sensory elements (visual, auditory, olfactory) on reducing discomfort in patients hospitalized in the intensive care unit\u002Fcontinuing care unit.",[27],"Hospitalism","RECRUITING","2026-06-12",{"date":31,"type":32},"2026-06-16","ACTUAL",{"date":34,"type":32},"2025-05-20",{"date":36,"type":21},"2027-01",{"name":38,"class":39},"GCS Ramsay Santé pour l'Enseignement et la Recherche","OTHER",1,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":22,"phases":52,"briefSummary":53,"conditions":54,"keywords":58,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":40},"100533955","alerting-providers-at-patient-hospital-discharge-to-consider-prescribing-rivaroxaban-to-reduce-venous-thromboembolism-100533955","NCT06232551","Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism","eVTE (Electronic Venous Thromboembolism): A Cluster, Randomized, Step-wedge Type II Hybrid Study of an Alert Recommending Extended Duration Thromboprophylaxis for At-risk Discharging Medical Patients to Prevent VTE.","eVTE","Inclusion Criteria:\n\n* Discharging clinician must be in one of the following iCentra electronic health record (Cerner, Kansas City, MO) positions:\n\n  * Physician, nurse practitioner, or physician assistant hospitalist\n  * Physician internal medicine\n  * Physician family medicine\n* Patient age ≥ 18 years.\n* The encounter must be inpatient.\n* A signed hospital discharge order must be present.\n* eVTE target population criteria (increased venous thromboembolism risk, low bleeding risk) must be met\n\nExclusion Criteria:\n\n* Pregnant during encounter\n* Discharge order completed by ineligible clinician type\n* Exclude all cases where the patient is being actively prescribed and intended to be discharged on the following qualifying anticoagulant medications, regardless of dose form or dosing regimen (i.e., they have an active prescription for one of these medications):\n\n  * Apixaban\n  * Dabigatran\n  * Dalteparin\n  * Enoxaparin\n  * Edoxaban\n  * Betrixaban\n  * Fondaparinux\n  * Rivaroxaban\n  * Warfarin\n* Creatinine clearance \\\u003C30 milliliters\u002Fminute based on last-available eligible serum creatinine value preceding discharge\n\n  * Estimated creatine clearance based on actual body weight (preferred) ((140 - age years) \\* measured weight kilograms) \u002F (72.0 \\* serum creatine milligrams\u002Fdeciliter) (\\*0.85 if female)) = milliliters\u002Fminute\n  * If measured body weight not available, then based on ideal body weight ((140 - age years) \\* ideal body weight kilograms) \u002F (72.0 \\* serum creatine milligrams\u002Fdeciliter) (\\*0.85 if female)) = milliliters\u002Fminute","110 Years",{"count":51,"type":21},152000,[24],"A new algorithm derived from only patient age and components of the complete blood count and basic metabolic panel can identify patients discharged from the hospital who may benefit from a blood thinner (called rivaroxaban) to decrease their risk of blood clots, and for whom the risk of bleeding is minimal.\n\nThe purpose of this study is to evaluate the use of a pop-up alert, which will be seen by clinicians when a discharging patient has been identified as being someone for whom the risk of blood clots is high, but for whom bleeding risk is estimated to be low.\n\nThe pop-up alert will be enabled in a sequential fashion for each group of hospitals in 1 month blocks. We will look to see if the pop-up alert changes the number of patients who receive rivaroxaban. We will also measure the outcomes of blood clots and bleeding among all discharging patients.",[55,56,57,27],"Venous Thromboembolic Disease","Pulmonary Embolism and Thrombosis","Deep Vein Thrombosis",[59,60,61,62,63],"post-discharge","extended duration thromboprophylaxis","rivaroxaban","direct oral anticoagulant","medical patient","2024-07-15",{"date":66,"type":32},"2024-07-17",{"date":68,"type":32},"2024-06-01",{"date":70,"type":21},"2025-09-30",{"name":72,"class":39},"Scott C. Woller, MD"]